1. Home
  2. EQS vs VVOS Comparison

EQS vs VVOS Comparison

Compare EQS & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equus Total Return Inc.

EQS

Equus Total Return Inc.

HOLD

Current Price

$1.74

Market Cap

18.9M

Sector

Finance

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.24

Market Cap

15.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQS
VVOS
Founded
1991
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
15.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
EQS
VVOS
Price
$1.74
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
2.5K
88.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.07
EPS
N/A
N/A
Revenue
N/A
$15,031,000.00
Revenue This Year
N/A
$31.42
Revenue Next Year
N/A
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.91
52 Week Low
$0.74
$1.28
52 Week High
$2.49
$7.40

Technical Indicators

Market Signals
Indicator
EQS
VVOS
Relative Strength Index (RSI) 78.39 32.01
Support Level $1.27 N/A
Resistance Level $1.86 $1.88
Average True Range (ATR) 0.06 0.12
MACD 0.04 -0.00
Stochastic Oscillator 97.92 6.25

Price Performance

Historical Comparison
EQS
VVOS

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: